SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549


                                   FORM 10-Q


               QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934



For The Quarter Ended: December 31, 2000  Commission File Number 0-19672
                       -----------------


                      American Superconductor Corporation
                      -----------------------------------
            (Exact name of registrant as specified in its charter)


            Delaware                                  04-2959321
- -------------------------------         ---------------------------------------
(State or other jurisdiction of         (I.R.S. Employer Identification Number)
 organization or incorporation)



                             Two Technology Drive
                       Westborough, Massachusetts 01581
                       --------------------------------
         (Address of principal executive offices, including zip code)



                                (508) 836-4200
                                --------------
             (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.

                                YES  X      NO
                                   -----      -----


Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.


Common Stock, par value $.01 per share                  20,255,596
- --------------------------------------      -----------------------------------
                Class                       Outstanding as of February 12, 2000

                      AMERICAN SUPERCONDUCTOR CORPORATION

                                     INDEX
                                     -----



                                                                               Page No.
                                                                               --------
Part I - Financial Information
                                                                            
  Consolidated Balance Sheets
     December 31, 2000 (unaudited) and March 31, 2000                              3

  Consolidated Statements of Operations
     for the three months ended
     December 31, 2000 and 1999 and the
     nine months ended December 31, 2000
     and 1999 (unaudited)                                                          4

  Consolidated Statements of Comprehensive Income (Loss)
     for the three months ended
     December 31, 2000 and 1999 and the
     nine months ended December 31, 2000
     and 1999 (unaudited)                                                          5

  Consolidated Statements of Cash Flows
     for the nine months ended
     December 31, 2000 and 1999 (unaudited)                                        6

  Notes to Interim Consolidated Financial Statements                              7-11

  Management's Discussion and Analysis of Financial
     Condition and Results of Operations                                         12-22

Part II - Other Information                                                       23

Signatures                                                                        24



                                       2

AMERICAN SUPERCONDUCTOR CORPORATION
Consolidated Balance Sheets

                                                                        December 31,           March 31,
                                                                            2000                 2000
                                                                        ------------         ------------
                                                                        (unaudited)
                             ASSETS
                                                                                       
Current assets:
      Cash and cash equivalents                                         $ 71,086,828         $126,917,768
      Accounts receivable                                                 13,479,844            7,317,009
      Inventory                                                           14,678,910            9,246,950
      Prepaid expenses and other current assets                            1,587,934              809,129
                                                                        ------------         ------------
          Total current assets                                           100,833,516          144,290,856

Property and equipment:
      Land                                                                 4,131,668                  -
      Construction in progress-Building                                    6,092,863                  -
      Equipment                                                           34,468,060           20,300,734
      Furniture and fixtures                                               2,050,109            1,670,029
      Leasehold improvements                                               3,174,820            3,006,814
                                                                        ------------         ------------

                                                                          49,917,520           24,977,577
Less: accumulated depreciation                                           (17,567,655)         (15,199,346)
                                                                        ------------         ------------

Property and equipment, net                                               32,349,865            9,778,231

Long-term marketable securities                                          108,190,876           91,737,449
Long-term accounts receivable                                              1,375,000            1,750,000
Net investment in sales-type lease                                           279,110              279,110
Goodwill                                                                   1,174,198                    0
Other assets                                                               1,650,315            1,078,610
                                                                        ------------         ------------
Total assets                                                            $245,852,880         $248,914,256
                                                                        ============         ============

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
      Accounts payable and accrued expenses                               $7,715,423           $6,339,023
      Deferred revenue                                                           -                371,250
                                                                        ------------         ------------

      Total current liabilities                                            7,715,423            6,710,273

Long-term deferred revenue                                                 3,418,473            1,259,883
Commitments

Stockholders' equity:
      Common stock, $.01 par value
          Authorized shares-50,000,000; issued and outstanding
             - 20,221,422 and 19,734,714 at December 31, 2000 and
             March 31, 2000, respectively                                    202,214              197,347
      Additional paid-in capital                                         355,265,781          348,903,034
      Deferred compensation                                                 (450,783)            (530,333)
      Deferred warrant costs                                                (411,631)            (637,552)
      Accumulated other comprehensive income (loss)                          560,740             (172,515)
      Accumulated deficit                                               (120,447,337)        (106,815,881)
                                                                        ------------         ------------
Total stockholders' equity                                               234,718,984          240,944,100
                                                                        ------------         ------------
Total liabilities and stockholders' equity                              $245,852,880         $248,914,256
                                                                        ============         ============


                 The accompanying notes are an integral part
                   of the consolidated financial statements.

                                       3

                      AMERICAN SUPERCONDUCTOR CORPORATION
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)



                                                         Three Months Ended                     Nine Months Ended
                                                            December 31,                           December 31,
                                                      2000               1999              2000                 1999
                                                  -----------        -----------        ----------          ------------
                                                                                                
Revenues:
      Contract revenue                            $ 1,005,198        $ 4,533,187        $  2,400,186        $  8,712,050
      Product sales and prototype
           development contracts                    4,601,640            498,627          11,848,494           1,123,179
                                                  -----------        -----------        ------------        ------------
           Total revenues                           5,606,838          5,031,814          14,248,680           9,835,229

Costs and expenses:
      Costs of  revenue - Contracts                   998,156          4,522,358           2,384,593           8,650,294
      Costs of  revenue - Product sales and
           prototype development contracts          3,106,913            560,989           8,867,111           1,247,904
      Research and development                      5,106,967          2,263,876          16,445,107           8,999,343
      Selling, general and administrative           3,673,750            797,941          10,343,976           4,481,563
                                                  -----------        -----------        ------------        ------------

           Total costs and expenses                12,885,786          8,145,164          38,040,787          23,379,104

Interest income                                     3,117,357            226,425          10,111,087             871,203
Other income (expense), net                            31,837              3,601              49,564               5,932
                                                  -----------        -----------        ------------        ------------

Net loss                                          $(4,129,754)       $(2,883,324)       $(13,631,456)       $(12,666,740)
                                                  ===========        ===========        ============        ============

Net loss per common share
      Basic                                       $     (0.20)       $     (0.19)       $      (0.68)       $      (0.82)
                                                  ===========        ===========        ============        ============

      Diluted                                     $     (0.20)       $     (0.19)       $      (0.68)       $      (0.82)
                                                  ===========        ===========        ============        ============

Weighted average number of
      common shares outstanding
      Basic                                        20,212,281         15,554,214          20,083,930          15,464,834
                                                  ===========        ===========        ============        ============

      Diluted                                      20,212,281         15,554,214          20,083,930          15,464,834
                                                  ===========        ===========        ============        ============





                  The accompanying notes are an integral part
                   of the consolidated financial statements.


                                       4

                      AMERICAN SUPERCONDUCTOR CORPORATION
            CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
                                  (Unaudited)



                                                  Three Months Ended                     Nine Months Ended
                                                     December 31,                           December 31,
                                                2000               1999               2000                1999
                                            ------------       ------------       -------------       -------------
                                                                                          
Net loss                                    ($4,129,754)       ($2,883,324)       ($13,631,456)       ($12,666,740)
Other comprehensive income (loss)
      Foreign currency translation               31,732             (8,148)             13,943              (9,337)
      Unrealized gains (losses)
           on investments                       394,129            (39,033)            719,312             (74,475)
                                            -----------        -----------        ------------        ------------
Other comprehensive income (loss)               425,861            (47,181)            733,255             (83,812)

Comprehensive income (loss)                 $(3,703,893)       $(2,930,505)       $(12,898,201)       $(12,750,552)
                                            ===========        ===========        ============        ============



                  The accompanying notes are an integral part
                   of the consolidated financial statements.


                                       5

                      AMERICAN SUPERCONDUCTOR CORPORATION

                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (Unaudited)



                                                                                     Nine Months Ended
                                                                                        December 31,
                                                                                   2000              1999
                                                                                   ----              ----
                                                                                           
Cash flows from operating activities:
       Net loss                                                                $(13,631,456)     $(12,666,740)
       Adjustments to reconcile net loss to net cash used by operations:
           Depreciation and amortization                                          2,688,141         1,529,176
           Deferred compensation expense                                             79,550              -
           Deferred warrant costs                                                   265,888           334,813
           Stock compensation expense                                               165,586            96,962
           Changes in operating asset and liability accounts :
                  Accounts receivable                                            (5,735,557)       (3,194,799)
                  Inventory                                                      (5,171,980)       (2,964,708)
                  Prepaid expenses and other current assets                        (778,805)          (82,763)
                  Accounts payable and accrued expenses                           1,376,400         1,217,900
                  Deferred revenue - current and long-term                        1,787,340         1,583,883
                                                                               ------------      ------------
       Total adjustments                                                         (5,323,437)       (1,479,536)

       Net cash used by operating activities                                    (18,954,893)      (14,146,276)

Cash flows from investing activities:
           Purchase of property and equipment (net)                             (24,734,414)       (4,571,403)
           Purchase of long-term marketable securities                          (15,734,115)         (315,467)
           Purchase of assets of Integrated Electronics, LLC                       (755,000)             -
           Net investment in sales-type lease                                           -               8,000
           Increase in other assets                                                (736,454)         (394,224)
                                                                               ------------      ------------

       Net cash used in investing activities                                    (41,959,983)       (5,273,094)

Cash flows from financing activities:
           Net proceeds from issuance of common stock                             5,083,936         1,950,777
                                                                               ------------      ------------

       Net cash provided by financing activities                                  5,083,936         1,950,777

Net increase (decrease) in cash and cash equivalents                            (55,830,940)      (17,468,593)

Cash and cash equivalents at beginning of period                                126,917,768        24,969,142
                                                                               ------------      ------------

Cash and cash equivalents at end of period                                     $ 71,086,828      $  7,500,549
                                                                               ============      ============

Supplemental schedule of cash flow information:
           Noncash issuance of common stock                                    $  1,323,261      $     96,962



                  The accompanying notes are an integral part
                   of the consolidated financial statements.


                                       6

                      AMERICAN SUPERCONDUCTOR CORPORATION

              NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


1. Nature of the Business:
   -----------------------

   American Superconductor Corporation (the "Company"), which was formed on
   April 9, 1987, is a world leader in developing and manufacturing products
   using superconducting materials and power electronic devices for electric
   power applications. The focus of the Company's development and
   commercialization efforts is on electrical equipment for use by electric
   utilities and industrial and commercial users of electrical power. For large-
   scale applications, the Company's development efforts are focused on high
   temperature superconducting ("HTS") power transmission cables, motors,
   generators and transformers. In the area of industrial power quality and
   transmission network power reliability, the Company is focused on marketing
   and selling commercial superconducting magnetic energy storage ("SMES")
   devices, on development and commercialization of new SMES products, on
   development of power electronic subsystems, and on providing engineering
   services in the area of power quality and transmission network reliability
   for industrial, commercial and utility customers. The Company operates in two
   business segments.

   The Company currently derives a substantial portion of its revenue from
   research and development contracts. A significant portion of this contract
   revenue relates to a development contract with Pirelli Cables and Systems
   ("Pirelli"), who (through an affiliated company) is a stockholder of the
   Company.

   Costs of revenue include research and development and selling, general and
   administrative expenses that are incurred in the performance of these
   development contracts.

   Research and development and selling, general and administrative expenses
   included as costs of revenue were as follows:



                                          Three         Three          Nine          Nine
                                          Months        Months        Months        Months
                                           Ended         Ended         Ended         Ended
                                        12/31/2000    12/31/1999    12/31/2000    12/31/1999
                                        ----------    ----------    ----------    ----------
                                                                      
Research and development expenses       $1,742,079    $3,286,565    $4,197,852    $6,459,655
Selling, general and administrative
expenses                                $  577,120    $1,759,208    $1,328,360    $3,297,263



2. Basis of Presentation:
   ----------------------

   The accompanying consolidated financial statements are unaudited, except for
   those dated as of March 31, 2000, and have been prepared in accordance with
   generally accepted accounting principles. Certain information and footnote
   disclosure normally included in the Company's annual consolidated financial
   statements have been condensed or omitted. The interim consolidated financial
   statements, in the opinion of management, reflect all adjustments (consisting
   of normal recurring accruals) necessary for a fair presentation of the
   results for the interim periods ended December 31, 2000 and 1999 and the
   financial position at December 31, 2000.


                                       7

                      AMERICAN SUPERCONDUCTOR CORPORATION

         NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, Continued


   The results of operations for the interim periods are not necessarily
   indicative of the results of operations to be expected for the fiscal year.
   It is suggested that these interim consolidated financial statements be read
   in conjunction with the audited consolidated financial statements for the
   year ended March 31, 2000 which are contained in the Company's Annual Report
   on Form 10-K covering the year ended March 31, 2000.

   On June 1, 2000, the Company acquired substantially all of the assets of
   Integrated Electronics, LLC ("IE"). The IE acquisition was accounted for
   under the purchase method of accounting. Goodwill of $1,329,282 represented
   the excess of the purchase price of $1,833,125 over the fair value of the
   acquired assets of $503,843 at June 1, 2000. The purchase price consisted of
   cash paid to IE of $675,000, miscellaneous transaction costs of $80,000, and
   the value of 37,500 shares of the Company's common stock at June 1, 2000 of
   $1,078,125. The fair value of the assets acquired were accounts receivable of
   $52,278, inventory of $259,980, and fixed assets of $191,585. These asset
   purchases are included under "Purchase of assets of Integrated Electronics,
   LLC" in the Consolidated Statements of Cash Flows for the period ended
   December 31, 2000 and thus are excluded from the "Changes in operating asset
   and liability accounts" section of the Consolidated Statements of Cash Flows.

   Certain prior year amounts have been reclassified to be consistent with the
   current year presentation.


3. Net Loss Per Common Share:
   --------------------------

   The Company adopted Statement of Financial Accounting Standards ("SFAS") No.
   128, "Earnings Per Share" effective December 28, 1997. SFAS No. 128 requires
   presentation of basic earnings per share ("EPS") and, for companies with
   complex capital structures, diluted EPS. Basic EPS excludes dilution and is
   computed by dividing net income available to common stockholders by the
   weighted-average number of common shares outstanding for the period. Diluted
   EPS includes dilution and is computed using the weighted average number of
   common and dilutive common equivalent shares outstanding during the period.
   Common equivalent shares include the effect of the exercise of stock options.
   For the three months ended December 31, 2000 and 1999, common equivalent
   shares of 2,450,138 and 1,543,813 were not included for the calculation of
   diluted EPS as they were considered antidilutive. For the nine months ended
   December 31, 2000 and 1999, common equivalent shares of 2,524,041 and
   3,391,891 were also not included for the calculation of diluted EPS as they
   were also considered antidilutive.


4. Cost-Sharing Agreements:
   -----------------------

   The Company received funding of approximately $4,000 under a U.S. Air Force
   cost-sharing agreement in the three months ended December 31, 2000, compared
   to approximately $347,000 from two Department of Energy cost-sharing
   agreements in the three months ended December 31, 1999. For the nine months
   ended December 31, 2000 and 1999, government cost-sharing funding was
   approximately $198,000 and $1,446,000, respectively. This funding was used to
   directly offset research and development and selling, general and
   administrative expenses.


                                       8

                      AMERICAN SUPERCONDUCTOR CORPORATION

         NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, Continued


5. Business Segment Information:
   -----------------------------

   The Company adopted Statement of Financial Accounting Standard No. 131,
   "Disclosures about Segments of an Enterprise and Related Information" ("FAS
   131"), as of March 31, 1999. The Company has two reportable business segments
   as defined by FAS 131-High Temperature Superconducting ("HTS") business
   segment, and the Superconducting Magnetic Energy Storage ("SMES") segment.

   The HTS business segment develops and commercializes HTS wire, wire products
   and systems. The focus of this segment's development efforts is on HTS wire
   for power transmission cables, motors, generators and transformers.

   The SMES business segment is focused on marketing and selling commercial SMES
   devices, on development and commercialization of new SMES products, on
   development of power electronic subsystems and on providing engineering
   services in the area of power quality and transmission network reliability
   for industrial, commercial and utility customers.

   The operating segment results for the HTS and SMES business segments were as
   follows:



                                                      Three Months Ended December 31       Nine Months Ended December 31
                                                      ------------------------------      -------------------------------
                                                          2000              1999               2000              1999
                                                      ------------      ------------      -------------      -------------
                                                                                                 
Revenues
- --------
 HTS                                                  $  2,110,869      $  4,967,931      $   5,305,806      $   9,249,385
 SMES                                                    3,495,969            63,883          8,942,874            585,844
                                                      ------------      ------------      -------------      -------------
     Total                                            $  5,606,838      $  5,031,814      $  14,248,680      $   9,835,229
                                                      ============      ============      =============      =============

Operating Income (loss)
- -----------------------
 HTS                                                  $ (6,118,182)     $ (1,034,768)     $ (18,926,676)     $  (7,639,802)
 SMES                                                     (835,622)       (1,810,922)        (3,869,712)        (5,031,246)
 Unallocated Corporate Expenses                           (325,144)         (267,660)          (995,719)          (872,827)
                                                      ------------      ------------      -------------      -------------
     Total                                             $(7,278,948)     $ (3,113,350)     $ (23,792,107)      $(13,543,875)
                                                      ============      ============      =============      =============




                                       9

                      AMERICAN SUPERCONDUCTOR CORPORATION

         NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, Continued


   The segment assets for the HTS and SMES business segments were as follows:



                                                      December 31, 2000        March 31, 2000
                                                      -----------------        --------------
                                                                         
   HTS                                                  $ 38,642,372            $ 16,265,634
   SMES                                                   27,932,804              13,993,405
   Corporate cash and marketable securities              179,277,704             218,655,217
                                                        ------------            ------------
   Total                                                $245,852,880            $248,914,256
                                                        ============            ============



   The accounting policies of the business segments are the same as those
   described in Note 2, except that certain corporate expenses which we do not
   believe are specifically attributable or allocable to either business segment
   have been excluded from the segment operating losses.


6. New Accounting Pronouncements:
   -----------------------------

   In June 1998, the Financial Accounting Standards Board issued Statement of
   Financial Accounting Standards No. 133, "Accounting for Derivative
   Instruments and Hedging Activities". The Statement establishes accounting and
   reporting standards requiring that every derivative instrument (including
   certain derivative instruments embedded in other contracts) be recorded in
   the balance sheet as either an asset or liability measured at its fair value.
   The Statement requires that changes in the derivative's fair value be
   recognized currently in earnings unless specific hedge accounting criteria
   are met. Special accounting for qualifying hedges allows a derivative's gains
   and losses to offset related results on the hedged item in the income
   statement, and requires that a company must formally document, designate and
   assess the effectiveness of transactions that receive hedge accounting.

   Statement 133, as amended by Statement 138, effective July 1, 2000, is
   effective for fiscal years beginning after June 15, 1999. In June 1999, FASB
   issued Statement 137 which defers the effective date to fiscal years
   beginning after June 15, 2000. A company may also implement the Statement as
   of the beginning of any fiscal quarter after issuance. Statement 133 cannot
   be applied retroactively. Statement 133 must be applied to (a) derivative
   instruments and (b) certain derivative instruments embedded in hybrid
   contracts that were issued, acquired or substantively modified after December
   31, 1997 (and, at the company's election, before January 1, 1998). We believe
   the impact on our financial statements of adopting Statement 133 will be
   immaterial.

   In December 1999, the SEC issued Staff Accounting Bulletin ("SAB") 101,
   "Revenue Recognition," which outlines the basic criteria that must be met to
   recognize revenue and provides guidance for presentation of revenue and for
   disclosure related to revenue recognition policies in financial statements
   filed with the SEC. The SEC has subsequently delayed the implementation date
   of SAB 101 until no later than the fourth fiscal quarter of fiscal years
   beginning after December 15, 1999. We believe the future impact on our
   financial statements as a result of SAB 101 will be immaterial.


                                      10

                      AMERICAN SUPERCONDUCTOR CORPORATION

         NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, Continued


   In March 2000, the FASB issued Interpretation No. 44 ("FIN 44"), "Accounting
   for Certain Transactions Involving Stock Compensation - an Interpretation of
   APB Opinion No. 25". This interpretation clarifies (a) the definition of
   employee for purposes of applying Opinion 25, (b) the criteria for
   determining whether a plan qualifies as a noncompensatory plan, (c) the
   accounting consequence of various modifications to the terms of a previously
   fixed stock option or award, and (d) the accounting for an exchange of stock
   compensation awards in a business combination. This interpretation is
   effective July 1, 2000, but certain conclusions in this interpretation cover
   specific events that occur after either December 15, 1998, or January 12,
   2000. To the extent that this interpretation covers events occurring during
   the period after December 15, 1998, or January 12, 2000, but before the
   effective date of July 1, 2000, the effects of applying this interpretation
   are recognized on a prospective basis from July 1, 2000. There is no impact
   on our financial statements in the current quarter as a result of adopting
   FIN 44. We believe the future impact on our financial statements as a result
   of this interpretation will be immaterial.


                                      11


                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


Results of Operations
- ---------------------

Total revenues during the three months ended December 31, 2000 were $5,607,000,
compared to $5,032,000 for the same period a year earlier. For the nine months
ended December 31, 2000, revenues were $14,249,000, as compared to $9,835,000
for the comparable period in 1999. Revenues for the three and nine-month periods
increased by $575,000 and $4,414,000, respectively, compared to the same prior-
year periods. The increase in revenue resulted from higher sales of
Superconducting Magnetic Energy Storage (SMES) products.  SMES sales in the
quarter were $3,496,000, compared to $64,000 during the third quarter of last
year, an increase of $3,432,000. SMES sales for the recent nine-month period
were $8,943,000, compared to $586,000 recorded during the first nine months of
last year, an increase of $8,357,000.

These increases in SMES sales were partially offset by lower HTS business unit
revenues, which decreased by $2,857,000 and $3,943,000 for the three and nine-
month periods ended December 31, 2000, respectively, compared to the same prior-
year periods. In the quarter ended December 31, 2000, total HTS revenues were
$2,111,000, as compared to $4,968,000 in the prior-year quarter. HTS contract
revenue decreased to $775,000 in the quarter ended December 31, 2000 from
$4,478,000 in the year-ago quarter. The year-ago quarter included $3,000,000 of
revenue from a research and development contract with Pirelli Cables and
Systems, which became effective October 1, 1999.  Included in the $3,000,000 of
Pirelli-related contract revenue was $2,500,000 of retroactive funding for work
performed prior to October 1, 1999. Pirelli-related contract revenue for the
quarter ended December 31, 2000 was $500,000. HTS revenues from product sales
and prototype development contracts increased to $1,336,000 in the quarter ended
December 31, 2000, compared to $490,000 in the prior-year period, partially
offsetting the decline in contract revenue.  For the nine-month periods ended
December 31, 2000 and 1999, total HTS revenues were $5,306,000 and $9,249,000,
respectively, a decrease caused by lower contract revenues.

For the three months ended December 31, 2000, we recorded approximately $4,000
of funding  under a new $1,500,000 government cost-sharing agreement with the U.
S. Air Force, which became effective December 18, 2000. For the three months
ended December 31, 1999, we recorded  $347,000 of funding under two cost sharing
agreements with the Department of Energy ("DOE").  For the nine months ended
December 31, 2000, funding under government cost-sharing agreements was
$198,000, compared to $1,446,000 for the comparable period in 1999. We
anticipate that a portion of our funding in the future will continue to come
from cost-sharing agreements as we continue to develop joint programs with
government agencies.  Funding from government cost-sharing agreements is
recorded as an offset to research and development and selling, general and
administrative expenses, as required by government contract accounting
guidelines, rather than as revenues.


                                      12


                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


Total costs and expenses for the three months ended December 31, 2000 were
$12,886,000, compared to $8,145,000 for the same period last year.  Total costs
and expenses for the first nine months of the current fiscal year were
$38,041,000, compared to $23,379,000 for the same period last year. The increase
in costs and expenses was primarily the result of our increased investment in
research and development and increased costs of revenue associated mainly with
the higher level of SMES product sales.

Adjusted research and development ("R&D") expenses, which include amounts
classified as costs of revenue and amounts offset by cost sharing funding,
increased to $6,851,000 in the three months ended December 31, 2000 from
$5,730,000 for the same period of the prior year. For the nine-month periods
ended December 31, 2000 and 1999, adjusted research and development expenses
were $20,745,000 and $16,204,000, respectively. These increases were due to the
continued scale-up of our internal research and development activities,
including the hiring of additional personnel and the purchases of materials and
equipment, and higher spending on licenses and consultants/outside contractors.
A portion of the R&D expenditures related to externally funded development
contracts has been classified as costs of revenue (rather than as R&D expenses).
A significantly higher proportion of R&D expenditures was classified as costs of
revenue in the year-ago periods due to the higher level of Pirelli and other
contract revenues. Additionally, a portion of R&D expenses was offset by cost
sharing funding.  Net R&D expenses (exclusive of amounts classified as costs of
revenues and amounts offset by cost sharing funding) increased to $5,107,000 in
the quarter ended December 31, 2000 from $2,264,000 for the same period last
year.  For the nine months ended December 31, 2000 and 1999, these amounts were
$16,445,000 and $8,999,000, respectively.

Our R&D expenditures are summarized as follows:



                                             Three Months   Three Months    Nine Months     Nine Months
                                                 Ended          Ended          Ended           Ended
                                              12/31/2000     12/31/1999     12/31/2000      12/31/1999
                                              ----------     ----------     ----------      ----------
                                                                                
R&D expenses per Consolidated
Statements of Operations..................    $5,107,000     $2,264,000     $16,445,000     $ 8,999,000
R&D expenditures on development
contracts classified as Costs of revenue..     1,742,000      3,287,000       4,198,000       6,460,000
R&D expenditures offset by cost sharing
funding...................................         2,000        179,000         102,000         745,000
                                              ----------     ----------     -----------     -----------

Adjusted R&D expenses                         $6,851,000     $5,730,000     $20,745,000     $16,204,000
                                              ==========     ==========     ===========     ===========


Adjusted selling, general and administrative ("SG&A") expenses, which include
amounts classified as costs of revenue and amounts offset by cost sharing
funding, increased to $4,253,000 for the three months ended December 31, 2000,
compared to $2,725,000 for the same period a year earlier. For the nine-month
periods ended December 31, 2000 and 1999, adjusted


                                      13

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


SG&A expenses were $11,768,000 and $8,479,000, respectively. These increases
were primarily due to the hiring of additional personnel and related expenses
incurred to support corporate development, marketing, and recruiting activities
and future planned growth. A portion of the SG&A expenditures related to
externally funded development contracts has been classified as costs of revenue
(rather than as SG&A expenses). A significantly higher proportion of SG&A
expenditures was classified as costs of revenue in the year-ago periods due to
the higher level of Pirelli and other contract revenues. Additionally, a
portion of SG&A expenses was offset by cost sharing funding. Net SG&A expenses
(exclusive of amounts classified as costs of revenues and amounts offset by cost
sharing funding) increased to $3,674,000 in the quarter ended December 31, 2000
from $798,000 for the same period last year. For the nine months ended December
31, 2000 and 1999, these amounts were $10,344,000 and $4,482,000, respectively.


Our SG&A expenditures are summarized as follows:



                                             Three Months   Three Months   Nine Months     Nine Months
                                                 Ended          Ended          Ended           Ended
                                              12/31/2000     12/31/1999     12/31/2000      12/31/1999
                                              ----------     ----------     ----------      ----------
                                                                                
SG&A expenses per Consolidated
Statements of Operations..................    $3,674,000     $  798,000     $10,344,000     $4,482,000
SG&A expenditures on development
contracts classified as Costs of revenue..       577,000      1,759,000       1,328,000      3,297,000
SG&A expenditures offset by cost
sharing funding...........................         2,000        168,000          96,000        700,000
                                              ----------     ----------     -----------     ----------
                                              $4,253,000     $2,725,000     $11,768,000     $8,479,000
Adjusted SG&A expenses                        ==========     ==========     ===========     ==========



Interest income was $3,117,000 in the quarter ended December 31, 2000 compared
to $226,000 for the same period in the previous year. For the nine months ended
December 31, 2000 and 1999, these amounts were $10,111,000 and $871,000,
respectively.  These increases in interest income reflect the higher cash
balances available for investment as a result of receiving $205,625,000 in net
proceeds from our March, 2000 public offering of 3,500,000 shares of common
stock.

We expect to continue to incur operating losses for the next two years, as we
continue to devote significant financial resources to our research and
development activities and commercialization efforts.

We expect to be party to agreements which, from time to time, may result in
costs incurred exceeding expected revenues under such contracts.  We may enter
into such agreements for a variety of reasons including, but not limited to,
entering new product application areas, furthering


                                      14

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


the development of key technologies, and advancing the demonstration of
commercial prototypes in critical market applications.

Please refer to the "Future Operating Results" section below for a discussion of
certain factors that may affect our future results of operations and financial
condition.


Liquidity and Capital Resources
- -------------------------------

At December 31, 2000, we had cash, cash equivalents and long-term marketable
securities of $179,278,000 compared to $218,655,000 at March 31, 2000. The
principal uses of cash during the nine months ended December 31, 2000 were the
funding of our operations, the acquisition of capital equipment, primarily for
research and development and manufacturing, and expenditures for our planned new
HTS manufacturing facility in Devens, Massachusetts.

Long-term accounts receivable of $1,375,000 represents the amount due after
December 31, 2001 on the $2,500,000 recognized as revenue in the year ended
March 31, 2000 for R&D work performed by us prior to the effective date (October
1, 1999) of the Pirelli development agreement. The $2,500,000 payment by Pirelli
for R&D performed before October 1, 1999 is guaranteed by the agreement and is
payable in quarterly installments over the five-year period between October 1,
1999 and September 30, 2004.

Goodwill of $1,174,000 at December 31, 2000 represents the excess of the
purchase price paid for the acquisition of substantially all of the assets of
Integrated Electronics, LLC ("IE") on June 1, 2000, over the fair value of IE's
assets, less amortization. The IE transaction was accounted for under the
purchase method of accounting. Goodwill was initially calculated to be
$1,329,000, and is being amortized over a five-year period beginning June 1,
2000, in an amount equal to $22,000 per month. Results of operations for IE
since June 1, 2000 are incorporated in our consolidated financial results.

We have potential funding commitments (excluding amounts included in accounts
receivable) of approximately $15,264,000 to be received after December 31, 2000
from strategic partners and government and commercial customers, compared to
$20,064,000 at March 31, 2000. However, these commitments, including $3,835,000
on U.S. government contracts, are subject to certain cancellation provisions. Of
the current commitment amount of $15,264,000, approximately 48% is potentially
collectable within the next 12 months.

To date, inflation has not had a material impact on our financial results.


                                      15

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


New Accounting Pronouncements
- -----------------------------

In June 1998, the Financial Accounting Standards Board ("FASB") issued Statement
of Financial Accounting Standards No. 133, "Accounting for Derivative
Instruments and Hedging Activities." The Statement establishes accounting and
reporting standards requiring that every derivative instrument (including
certain derivative instruments embedded in other contracts) be recorded in the
balance sheet as either an asset or liability measured at its fair value. The
Statement requires that changes in the derivative instrument's fair value be
recognized currently in earnings unless specific hedge accounting criteria are
met. Special accounting for qualifying hedges allows a derivative's gains and
losses to offset related results on the hedged item in the income statement, and
requires that a company must formally document, designate and assess the
effectiveness of transactions that receive hedge accounting.

Statement 133, as amended by Statement 138, effective July 1, 2000, is effective
for fiscal years beginning after June 15, 1999. In June 1999, FASB issued
Statement 137 which defers the effective date to fiscal years beginning after
June 15, 2000.  A company may also implement the Statement as of the beginning
of any fiscal quarter after issuance. Statement 133 cannot be applied
retroactively. Statement 133 must be applied to (a) derivative instruments and
(b) certain derivative instruments embedded in hybrid contracts that were
issued, acquired or substantively modified after December 31, 1997 (and, at the
company's election, before January 1, 1998). We believe the impact on our
financial statements of adopting Statement 133 will be immaterial.

In December 1999, the SEC issued Staff Accounting Bulletin ("SAB") 101,"Revenue
Recognition," which outlines the basic criteria that must be met to recognize
revenue and provides guidance for presentation of revenue and for disclosure
related to revenue recognition policies in financial statements filed with the
SEC. The SEC has subsequently delayed the implementation date of SAB 101 until
no later than the fourth fiscal quarter of fiscal years beginning after
December 15, 1999. We believe the future impact on our financial statements as a
result of SAB 101 will be immaterial.

In March 2000, the FASB issued Interpretation No. 44 ("FIN 44"), "Accounting for
Certain Transactions Involving Stock Compensation - an Interpretation of APB
Opinion No. 25". This Interpretation clarifies (a) the definition of employee
for purposes of applying Opinion 25, (b) the criteria for determining whether a
plan qualifies as a noncompensatory plan, (c) the accounting consequence of
various modifications to the terms of a previously fixed stock option or award,
and (d) the accounting for an exchange of stock compensation awards in a
business combination. This Interpretation is effective July 1, 2000, but certain
conclusions in this Interpretation cover specific events that occur after either
December 15, 1998, or January 12, 2000. To the extent that this Interpretation
covers events occurring during the period after December 15, 1998, or January
12, 2000, but before the effective date of July 1, 2000, the effects of applying
this Interpretation are recognized on a prospective basis from July 1, 2000.
There is no impact on our financial statements in the current quarter as a
result of adopting FIN 44.  We believe the future impact on our financial
statements as a result of this interpretation will be immaterial.


                                      16

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


Quantitative and Qualitative Disclosures About Market Risk
- ----------------------------------------------------------

Our exposure to market risk through derivative financial instruments and other
financial instruments, such as investments in short-term marketable securities
and long-term debt, is not material.


                            FUTURE OPERATING RESULTS

Various statements included herein, as well as other statements made from time
to time by our representatives, which relate to future matters (including but
not limited to statements concerning our future commercial success) constitute
forward looking statements and are made under the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. There are a number of
important factors which could cause our actual results of operations and
financial condition in the future to vary from that indicated in such forward
looking statements. Factors that may cause such differences include, without
limitation, the risks, uncertainties and other information set forth below.


We have a history of operating losses and we expect to continue to incur losses
in the future.

  We have been principally engaged in research and development activities. We
have incurred net losses in each year since our inception. Our net loss for
fiscal 1998, fiscal 1999, fiscal 2000, and the first nine months of fiscal 2001
was $12,378,000, $15,326,000, $17,598,000, and $13,631,000, respectively. Our
accumulated deficit as of December 31, 2000 was $120,447,000. We expect to
continue to incur operating losses in the next two years and there can be no
assurance that we will ever achieve profitability.


There are a number of technological challenges that must be successfully
addressed before our superconducting products can gain widespread commercial
acceptance.

  Many of our products are in the early stages of commercialization and testing,
while others are still under development. We do not believe any company has yet
successfully developed and commercialized significant quantities of HTS wire or
wire products. There are a number of technological challenges that we must
successfully address to complete our development and commercialization efforts.
For example, we face engineering challenges in producing HTS wire in longer
lengths and commercial quantities. We also believe that several years of further
development in the cable and motor industries will be necessary before a
substantial number of additional commercial applications for our HTS wire in
these industries can be developed and


                                      17

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


proven. We may also need to improve the quality of our HTS wire to expand the
number of commercial applications for it. We may be unable to meet such
technological challenges. Delays in development, as a result of technological
challenges or other factors, may result in the introduction of our products
later than anticipated.


The commercial uses of superconducting products are very limited today, and a
widespread commercial market for our products may not develop.

  To date, there has been no widespread commercial use of HTS products. Although
LTS products are currently used in several commercial applications, commercial
acceptance of LTS products, other than for medical magnetic resonance imaging
and superconducting magnetic energy storage products, has been significantly
limited by the cooling requirements of LTS materials. Even if the technological
hurdles currently limiting commercial uses of HTS and LTS products are overcome,
it is uncertain whether a robust commercial market for those new and unproven
products will ever develop. It is possible that the market demands we currently
anticipate for our HTS and LTS products will not develop and that
superconducting products will never achieve widespread commercial acceptance.


We expect to spend significant amounts on the expansion of our manufacturing
capacity, and our expansion projects may not be successful.

  In anticipation of significantly increased demand for our products, we have
announced plans to build a facility exclusively dedicated to HTS wire
manufacturing at the Devens Commerce Center in Devens, Massachusetts, and have
begun construction of this facility.  Over the next two years, we plan to use a
portion of the net proceeds from our March 2000 stock offering to buy land,
construct a building and purchase equipment for the new HTS wire manufacturing
facility in Devens, and for a new SMES manufacturing facility. We can only
estimate the costs of these projects, and the actual costs may be significantly
in excess of our estimates. In addition, we may be unable to lease suitable
space for our new facilities on commercially acceptable terms, the completion of
those new facilities may be delayed, or we may experience start-up difficulties
or other problems once those facilities become operational. Finally, if
increased demand for our products does not materialize, we will not generate
sufficient revenue to offset the cost of establishing and operating these
facilities.


We have no experience manufacturing our products in commercial quantities.

  To be financially successful, we will have to manufacture our products in
commercial quantities at acceptable costs while also preserving the quality
levels achieved in manufacturing these products in limited quantities. This
presents a number of technological and engineering


                                      18

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


challenges for us. We cannot assure you that we will be successful in developing
product designs and manufacturing processes that permit us to manufacture our
HTS and SMES products in commercial quantities at commercially acceptable costs
while preserving quality. In addition, we may incur significant start-up costs
and unforeseen expenses in our product design and manufacturing efforts.


We have historically focused on research and development activities and have
limited experience in marketing and selling our products.

  We have been primarily focused on research and development of our
superconducting products. Consequently, our management team has limited
experience directing our commercialization efforts which are essential to our
future success. To date, we only have limited experience marketing and selling
our products, and there are very few people anywhere who have significant
experience marketing or selling superconducting products. Once our products are
ready for commercial use, we will have to develop a marketing and sales
organization that will effectively demonstrate the advantages of our products
over both more traditional products and competing superconducting products or
other technologies. We may not be successful in our efforts to market this new
and unfamiliar technology, and we may not be able to establish an effective
sales and distribution organization.

  We may decide to enter into arrangements with third parties for the marketing
or distribution of our products, including arrangements in which our products,
such as HTS wire, are included as a component of a larger product, such as a
motor. We have entered into a marketing and sales alliance with GE Industrial
Systems giving GE the exclusive right to offer our Distributed-SMES (D-SMES)
product line in the United States to utilities and the right to sell industrial
Power Quality-SMES (PQ-SMES) systems to certain of GE's global industrial
accounts.  By entering into marketing and sales alliances, the financial
benefits to us of commercializing our products are dependent on the efforts of
others. We may not be able to enter into marketing or distribution arrangements
with third parties on financially acceptable terms, and third parties may not be
successful in selling our products or applications incorporating our products.


We depend on our strategic relationships with our corporate partners for the
successful development and marketing of applications for our superconducting
products.

  Our business strategy depends upon strategic relationships with corporate
partners, which are intended to provide funding and technologies for our
development efforts and assist us in marketing and distributing our products.
Although we currently are party to a number of strategic relationships, we may
not be able to maintain these relationships, and these relationships may not be
technologically or commercially successful.


                                      19

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


  We have an agreement with Pirelli relating to HTS wire for cables used to
transmit both electric power and control signals. In general, we are obligated
to sell our HTS cable wire exclusively to Pirelli, and Pirelli is obligated to
buy this HTS wire exclusively from us or to pay us royalties for any of this
wire that it manufactures for use in these applications anywhere in the world
other than Japan. Pirelli continues to provide us with substantial funding and
has been critical in assisting us in the development and commercialization of
HTS cable wire. Consequently, we are significantly dependent on Pirelli for the
commercial success of this cable wire in these applications.

  As we move toward commercialization of several of our products, we plan to use
strategic alliances as an important means of marketing and selling our products.
We have entered into a marketing and sales alliance with GE giving GE the
exclusive right to offer our D-SMES product line in the United States to
utilities and the right to sell industrial PQ-SMES systems to certain of GE's
global industrial accounts. Any strategic relationships established may not
provide us with the commercial benefits we anticipate.

Our products face intense competition both from superconducting products
developed by others and from traditional, non-superconducting products and
alternative technologies.

  As we begin to market and sell our superconducting products, we will face
intense competition both from competitors in the superconducting field and from
vendors of traditional products and new technologies. There are many companies
in the United States, Europe, Japan and Australia engaged in the development of
HTS products, including 3M, Siemens, Alcatel and Sumitomo Electric Industries.
The superconducting industry is characterized by rapidly changing and advancing
technology. Our future success will depend in large part upon our ability to
keep pace with advancing HTS and LTS technology and developing industry
standards. In addition, our SMES products compete with a variety of non-
superconducting products such as dynamic voltage restorers and battery-based
power supply systems. Research efforts and technological advances made by others
in the superconducting field or in other areas with applications to the power
quality and reliability markets may render our development efforts obsolete.
Many of our competitors have substantially greater financial resources, research
and development, manufacturing and marketing capabilities than we have. In
addition, as the HTS, power quality and power reliability markets develop, other
large industrial companies may enter those fields and compete with us.


Third parties have or may acquire patents that cover the high temperature
superconducting materials we use or may use in the future to manufacture our
products.

  We expect that some or all of the HTS materials and technologies we use in
designing and manufacturing our products are or will become covered by patents
issued to other parties, including our competitors. If that is the case, we will
need either to acquire licenses to these patents or to successfully contest the
validity of these patents. The owners of these patents may


                                      20

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


refuse to grant licenses to us, or may be willing to do so only on terms that we
find commercially unreasonable. If we are unable to obtain these licenses, we
may have to contest the validity or scope of those patents to avoid infringement
claims by the owners of these patents. It is possible that we will not be
successful in contesting the validity or scope of a patent, or that we will not
prevail in a patent infringement claim brought against us. Even if we are
successful in such a proceeding, we could incur substantial costs and diversion
of management resources in prosecuting or defending such a proceeding.


There are numerous patents issued in the field of superconducting materials and
our patents may not provide meaningful protection for our technology.

  We own or have licensing rights under many patents and pending patent
applications. However, the patents that we own or license may not provide us
with meaningful protection of our technologies, and may not prevent our
competitors from using similar technologies, for a variety of reasons, such as
the following:

  .  The patent applications that we or our licensors file may not result in
     patents being issued.

  .  Patents and patent applications may be challenged by third parties. For
     example, several interference or opposition proceedings have been initiated
     with respect to patent applications or patents under which we hold
     exclusive licenses. These proceedings could result in a loss of patents or
     applications, which would also result in a loss of our rights under them;
     and in the case of an interference might also result in the issuance of a
     similar patent to the party initiating the interference proceeding.

  .  Others may independently develop similar technologies not protected by our
     patents or design around the patented aspects of any technologies we
     develop.

Moreover, we could incur substantial litigation costs in defending the validity
of our own patents. We also rely on trade secrets and proprietary know-how to
protect our intellectual property. However, our non-disclosure agreements and
other safeguards may not provide meaningful protection for our trade secrets and
other proprietary information.


Our success is dependent upon attracting and retaining qualified personnel.

  Our success will depend in large part upon our ability to attract and retain
highly qualified research and development, management, manufacturing, marketing
and sales personnel. Hiring those persons may be especially difficult due to the
specialized nature of our business. In addition, the demand for qualified
personnel is particularly acute in the New England and


                                      21

                      AMERICAN SUPERCONDUCTOR CORPORATION

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS FOR THE
                      NINE MONTHS ENDED DECEMBER 31, 2000


Wisconsin areas, where most of our operations are located, due to the currently
low unemployment rate in these regions.

  We are particularly dependent upon the services of Dr. Gregory J. Yurek, our
co-founder and our Chairman of the Board, President and Chief Executive Officer,
and Dr. Alexis P. Malozemoff, our Chief Technical Officer. The loss of the
services of either of those individuals could significantly damage our business
and prospects.


                                      22


                      AMERICAN SUPERCONDUCTOR CORPORATION

                                    PART II

                               OTHER INFORMATION

                                    ------


Item 1.  Legal Proceedings
         -----------------
         None

Item 2.  Changes in Securities and Use of Proceeds
         -----------------------------------------
         None

Item 3.  Defaults Upon Senior Securities
         -------------------------------
         None

Item 4.  Submission of Matters to a Vote of Security Holders
         ---------------------------------------------------
         None

Item 5.  Other Information
         -----------------
         None


                                      23

                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                      AMERICAN SUPERCONDUCTOR CORPORATION





February 14, 2001                          /s/ Gregory J. Yurek
- -------------------------------            ------------------------------------
Date                                       Gregory J. Yurek
                                           Chairman of the Board, President and
                                           Chief Executive Officer





February 14, 2001                          /s/ Thomas M. Rosa
- -------------------------------            ------------------------------------
Date                                       Thomas M. Rosa
                                           Chief Accounting Officer, Corporate
                                           Controller and Assistant Secretary


                                      24